These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6029114)

  • 1. Evaluation of the Belles-Littleman filter paper spot test. Tuberculosis prevention trial, Bangalore, South India.
    Am Rev Respir Dis; 1967 Jul; 96(1):17-27. PubMed ID: 6029114
    [No Abstract]   [Full Text] [Related]  

  • 2. Belles-Littleman filter paper spot test.
    Eidus L; Hamilton EJ
    Am Rev Respir Dis; 1968 Apr; 97(4):722-4. PubMed ID: 5651036
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasibility of a chemoprophylaxis trial in India against tuberculosis. A pilot study.
    Narain R; Mayurnath S; Rao MS; Murthy SS
    Bull World Health Organ; 1970; 43(1):41-52. PubMed ID: 5312321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reagent-impregnated paper strip for detection of metabolic products of isoniazid in urine.
    Kilburn JO; Beam RE; David HL; Sanchez E; Corpe RF; Dunn W
    Am Rev Respir Dis; 1972 Dec; 106(6):923-4. PubMed ID: 4641228
    [No Abstract]   [Full Text] [Related]  

  • 5. Point-of-care urine test for assessing adherence to isoniazid treatment for tuberculosis.
    Soobratty MR; Whitfield R; Subramaniam K; Grove G; Carver A; O'Donovan GV; Wu HH; Lee OY; Swaminathan R; Cope GF; Milburn HJ
    Eur Respir J; 2014 May; 43(5):1519-22. PubMed ID: 24435008
    [No Abstract]   [Full Text] [Related]  

  • 6. Slow and rapid inactivators of isoniazid among Greek patients.
    Farhat S; Jodanoglou J; Pallikaris G; Lyberatos K; Gardikas C; Hadjiidannou J
    Am Rev Respir Dis; 1973 Nov; 108(5):1242-3. PubMed ID: 4746586
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoniazid acetylator phenotyping of Amharas in Ethiopia.
    Russell SL; Russell DW
    Afr J Med Sci; 1973 Jan; 4(1):1-5. PubMed ID: 4695980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tubazid metabolism in patients with renal tuberculosis].
    Vilenskaia RN; Danilova NK; Kanevskaia SS
    Probl Tuberk; 1972; 50(8):65-8. PubMed ID: 5055504
    [No Abstract]   [Full Text] [Related]  

  • 9. Simplified isoniazid acetylator phenotyping.
    Russell DW; Eidus L
    Can Med Assoc J; 1972 Jun; 106(11):1155-6. PubMed ID: 5034694
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inactivation of PAS and isoniazid in children with tuberculosis].
    Shenderova RI; Terterian EA
    Probl Tuberk; 1973; 51(5):67-71. PubMed ID: 4757049
    [No Abstract]   [Full Text] [Related]  

  • 11. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
    Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE
    BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Antituberculosis chemotherapy: a resume of the rationale.
    Dhar S
    J Indian Med Assoc; 1973 Jun; 60(11):437-9. PubMed ID: 4127203
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
    Kislitsyna NA
    Probl Tuberk; 1985; (4):55-7. PubMed ID: 4001111
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled study of the effect of a domiciliary tuberculosis chemotherapy programme in a rural community in south India.
    Frimodt-Moller J; Acharyulu GS; Kesava Pillai K
    Indian J Med Res; 1981 Apr; 73 Suppl():1-80. PubMed ID: 7021410
    [No Abstract]   [Full Text] [Related]  

  • 15. [Errors in testing the INH content in the organism].
    Vilenskaia RN
    Probl Tuberk; 1970; 48(11):77-80. PubMed ID: 5516520
    [No Abstract]   [Full Text] [Related]  

  • 16. Isoniazid inactivation status and the development of chronic tuberculosis.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(3):227-34. PubMed ID: 5195905
    [No Abstract]   [Full Text] [Related]  

  • 17. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.
    Ellard GA; Ellard DR; Allen BW; Girling DJ; Nunn AJ; Teo SK; Tan TH; Ng HK; Chan SL
    Am Rev Respir Dis; 1986 Jun; 133(6):1076-80. PubMed ID: 3717760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients.
    Mattila MJ; Tiitinen H
    Ann Med Exp Biol Fenn; 1967; 45(4):423-7. PubMed ID: 5599058
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isoniazid--essential facts and recent advances].
    Zierski M; Rotermund C
    Prax Klin Pneumol; 1984 Jun; 38(6):201-16. PubMed ID: 6382240
    [No Abstract]   [Full Text] [Related]  

  • 20. Inactivation of isoniazid and sulphadimidine in mongoloid subjects.
    Airaksinen E; Mattila MJ; Ollila O
    Ann Med Exp Biol Fenn; 1969; 47(4):303-7. PubMed ID: 4246038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.